Create a profile to access all of our events, including options to sign up for our in person meetings and to view the online content from our past conferences!

Video Platform

View all the content from the last 12 months

MD Newsletter

Stay up to date with everything MD Education

Tickets & Events

Save your space and register for our future events

Select what applies to you


Gaining access to MD Education’s premium offerings is only a button away! Enter your email and password to get educated.

We're evolving!

The website is currently being upgraded to include our new suite of offerings. Check back at the end of the month for a breakdown of our new services!

Questions? Contact us at:

Want Cookies?

Currently, we're using cookies for tracking purposes. By tracking, we mean what pages of MD Education you visit, what forms you submit and how you interact with our site. We do not sell this data to anybody. Currently, the Cookies we use are needed to collect form data through HubSpot.

If you'd like to see what we do with your data, head over to our Privacy Policy

3rd Annual


EU Focus Meeting

International Knowledge & Clinical Practice in 2024

St. Ermin’s Hotel, London, UK

Friday 25 October 2024 - Saturday 26 October 2024

Presentations will be available online for 12 months

Meeting content distributed to 12,000+ HCPs

For more information get in touch!



Charlie Craddock, MD

Queen Elizabeth Hospital, Birmingham



Naval Daver, MD

MD Anderson Cancer Center, Houston, Texas



Cristina Papayannidis, MD

Austin Diagnostic Clinic, TX



Elias Jabbour, MD

MD Anderson Cancer Center, Houston, Texas

Dear Colleagues and Friends,

We are delighted to extend our warmest invitation to the multinational congress AML-ALL EU Focus 2024, to be held at St. Ermin’s Hotel, London, UK on 25 October 2024.

Centred around the theme "International Knowledge & Clinical Practice in 2024", this congress provides pivotal collaboration aimed at advancing AML-ALL research and patient treatment on a global scale.

This congress presents an opportunity for medical professionals to engage in the exchange of knowledge, expertise, and insights, as well as networking with leading experts from around the world.

Engage in riveting presentations, participate in thought-provoking debates and round-table discussions, and connect with peers at informal social gatherings.

All congress content will be accessible online for a full year, reaching an extensive audience of healthcare professionals worldwide.

People stood in a circle, smiling, with a cup of water

Agenda & Faculty

AML-ALL EU Focus Meeting, Friday 25 October 2024 - Saturday 26 October 2024


Registration Opens


Opening remarks – Ryan Fitzpatrick, CEO, MD Education

Session 1: TBD


Research and progress in AML


Hagop Kantarjian, MD

MD Anderson Cancer Center, Houston, Texas


Practical approach to incorporating genomics in treatment decision making in Fit adult AML


Paresh Vyas, MD

University of Oxford, UK


Incorporating MRD into treatment decision making in newly diagnosed AML, focus on NPM1 and FLT3 mutated AML


Christoph Röllig, MD

University Hospital Carl Gustav Carus, Dresden, Germany


Current status and updates in the diagnosis, prognosis


Peter J.M. Valk, MD

Erasmus University Medical Center, Rotterdam, Netherlands


Optimising transplant outcomes in high-risk AML?


Charlie Craddock, MD

Queen Elizabeth Hospital, Birmingham


Panel Discussion


Coffee Break

Session 2: TBD


Biology of Ph pos ALL: new insights for a risk stratification?


Ilaria Iacobucci, MD

St. Jude Children’s Research Hospital, US


How I treat Ph positive ALL in 2024: US


Elias Jabbour, MD

MD Anderson Cancer Center, Houston, Texas


How I treat Ph positive ALL in 2024: Europe


Phillippe Rousselot, MD

University of Versailles Saint-Quentin-en-Yvelines, France


SCT in Ph+ ALL: is it still necessary?


Jose Maria Ribera, MD

Catalan Institute of Oncology, Spain


Treatment strategies in Ph like ALL


Giovanni Martinelli, MD

IRST IRCCS, Meldola FC, Italy


Panel Discussion


Lunch Break, Networking & Group Photo


Independent Educational Session

Session 3: TBD


Which patients with newly diagnosed AML should receive a venetoclax based regimen in 2024


Naval Daver, MD

MD Anderson Cancer Center, Houston, Texas


Novel approaches to treatment of TP53m and other high-risk AML


Rami Komrokji, MD

Moffitt Cancer Center, Florida


Menin inhibitors in the management of AML


Emma Searle, MD

The Christie NHS Foundation Trust, Manchester, UK


Immunotherapeutic strategies in AML


Marion Subklewe, MD

University Hospital of Munich, Germany


Managament of disease relapse in fit and unfit AML patients


Alessandro Isidori, MD

Marche Nord Hospital, Pesaro, Italy


Panel Discussion


Coffee Break & Networking

Session 4: TBD


SCT in adult Ph neg ALL: how, when and for which patients?


Fabio Ciceri, MD

San Raffaele Hospital, Milan, Italy


CAR-T cells in ALL: progress and pitfalls


Marco Ruella, MD

University of Pennsylvania, Pennsylvania


Debate: R/R Ph neg ALL: CAR-T cells or antibodies?


CAR-T Cells

Claire Roddie, MD

University College London, UK



Nicolas Boissel, MD

Assistance Publique – Hôpitaux de Paris, France


Panel & Debate Discussion